Compare Essex Property Trust, Inc. (ESS) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Essex Property Trust, Inc. vs Inovio Pharmaceuticals Inc — how do they compare? Essex Property Trust, Inc. trades at $282.11 (market cap $18.15B), while Inovio Pharmaceuticals Inc trades at $0.73 (market cap $78.55M). The key difference: Essex Property Trust, Inc. is far larger — about 231.1× Inovio Pharmaceuticals Inc's market cap, and Essex Property Trust, Inc. pays a 3.93% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ESS | INO | |
|---|---|---|
Market Cap | $18.15B | $78.55M |
Sector | Real Estate | Health |
52-Week High | $298.33 | $2.87 |
52-Week Low | $239.61 | $0.66 |
Enterprise Value | $24.75B | $49.56M |
Dividend Yield | 3.93% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
INO shares trade at $0.74, up 10.24% today, but remain significantly below analyst consensus targets. The biotech firm shows improving operational trends with three consecutive quarterly earnings beats, though financials reveal substantial losses with -130% net margin. Technical indicators signal bearish momentum despite neutral oscillators. Key catalyst is the FDA's October 30, 2026 PDUFA date for INO-3107, with the company recently raising $20 million to fund operations.
Outlook hinges on FDA approval of INO-3107, representing a binary event that could drive substantial upside given the $3.25 consensus target. However, persistent cash burn, negative profitability metrics, and ongoing shareholder litigation pose significant risks. The stock offers high-risk, event-driven potential for speculative investors willing to accept regulatory and financial uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Essex Property Trust, Inc.
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
